Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl and Rocuronium for Tracheal Intubation in Newborns
NCT07650552Phase 4Not yet recruiting
- Sponsor
- Universidade do Estado do Amazonas
- Start
- Sep 2026
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of rocuronium in respiratory distress syndrome (RDS) and apnea of prematurity (AOP) (2 arms), sponsored by Universidade do Estado do Amazonas. Primary endpoint: First-attempt intubation success without physiological instability up to 5 minutes. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
rocuronium
03
Conditions
respiratory distress syndrome (RDS)apnea of prematurity (AOP)
Beyond the preview
Go deeper on NCT07650552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07650552.